Your browser doesn't support javascript.
loading
Phase II study of multidisciplinary therapy combined with pembrolizumab for patients with synchronous oligometastatic non-small cell lung cancer TRAP OLIGO study (WJOG11118L).
Miyawaki, Taichi; Kenmotsu, Hirotsugu; Harada, Hideyuki; Ohde, Yasuhisa; Chiba, Yasutaka; Haratani, Koji; Okimoto, Tamio; Sakamoto, Tomohiro; Wakuda, Kazushige; Ito, Kentaro; Uemura, Takehiro; Sakata, Shinya; Kogure, Yoshihito; Nishimura, Yasumasa; Nakagawa, Kazuhiko; Yamamoto, Nobuyuki.
Afiliación
  • Miyawaki T; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Kenmotsu H; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
  • Harada H; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. h.kenmotsu@scchr.jp.
  • Ohde Y; Radiation and Proton Therapy Center, Shizuoka Cancer Center, Shizuoka, Japan.
  • Chiba Y; Division of Thoracic Surgery, Shizuoka Cancer Center, Shizuoka, Japan.
  • Haratani K; Clinical Research Center, Kindai University Hospital, Osaka-sayama, Japan.
  • Okimoto T; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Sakamoto T; Department of Internal Medicine, Division of Medical Oncology & Respiratory Medicine, Shimane University Faculty of Medicine, Izumo, Japan.
  • Wakuda K; Division of Respiratory Medicine and Rheumatology, Department of Multidisciplinary Internal Medicine, Tottori University, Yonago city, Japan.
  • Ito K; Division of Thoracic Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Uemura T; Respiratory Centor, Matsusaka Municipal Hospital, Matsusaka, Japan.
  • Sakata S; Department of Respiratory Medicine, Allergy and Clinical Immunology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
  • Kogure Y; Department of Respiratory Medicine, Kumamoto University Hospital, Kumamoto, Japan.
  • Nishimura Y; Department of Respiratory Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Nakagawa K; Department of Radiation Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
  • Yamamoto N; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Japan.
BMC Cancer ; 21(1): 1121, 2021 Oct 18.
Article en En | MEDLINE | ID: mdl-34663250
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Inhibidores de Puntos de Control Inmunológico / Neoplasias Pulmonares Tipo de estudio: Clinical_trials Límite: Adult / Aged / Humans / Middle aged País/Región como asunto: Asia Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article País de afiliación: Japón